Multisystem inflammatory syndrome MIS-C in children after COVID-19 infection
DOI:
https://doi.org/10.15574/PP.2023.96.128Keywords:
child, COVID-19, pericarditis, exanthema, multisystem inflammatory syndromeAbstract
In recent years, the number of reported cases of multisystem inflammatory syndrome (MIS-C - Multisystem Inflammatory Syndrome in Children) in children after COVID-19 infection has been increasing. This syndrome usually manifests itself 4-8 weeks after the disease. It is necessary to learn how to diagnose it in time and prevent possible complications from the gastrointestinal tract, cardiovascular and other systems, and to pay attention to the prevention of children from COVID-19 infection through vaccination.
Purpose - to analyze the information from the current professional literature on the peculiarities of diagnosis, course and treatment of MIS-C in children after COVID-19 infection to expand the knowledge of doctors about this pathology by presenting clinical case.
We present a clinical case of MIS-C in a child after COVID-19 infection. The literature data from PubMed, Medscape, CDC, Mayo Clinic were analyzed. The peculiarity of the presented case is the long-term damage to the cardiovascular and respiratory systems, skin lesions, and the development of iron deficiency anemia. During her hospital stay, the girl's condition was severe due to asthenic, anemic syndrome, and cardiovascular damage.
Conclusions. The presented clinical observation confirms the complexity of the algorithm for diagnosing complications of COVID infection in children, especially in their asymptomatic course. Thus, pediatricians should be alert to the development of multisystem inflammatory syndrome MIS-C in children after COVID-19 infection and increase the level of knowledge about the correct diagnostic algorithm in such cases.
The study was conducted in accordance with the principles of the Declaration of Helsinki. The informed consent of the child’s parents was obtained for the study.
No conflict of interests was declared by the authors.
References
Anderson EM, Diorio C, Goodwin EC, McNerney KO, Weirick ME, Gouma S et al. (2020). SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19. J. Pediatric. Infect. Dis. Soc. 10 (5): 669-673. https://doi.org/10.1093/jpids/piaa161; PMid:33263756 PMCid:PMC7799010
Boyarchuk OR, Nykytyuk SO, Borys ZYa, Levenets SS, Shylo OR. (2022). Hepatic vein thrombosis in a child with COVID-19: clinical case. Modern Pediatrics. Ukraine. 3 (123): 94-99. https://doi.org/10.15574/SP.2022.123.94
Diggikar S, Nanjegowda R, Kumar A, Kumar V, Kulkarni S, Venkatagiri P. (2022). Neonatal multisystem inflammatory syndrome secondary to SARS-CoV-2 infection. J Paediatr Child Health. 58: 900-902. https://doi.org/10.1111/jpc.15696; PMid:34388280 PMCid:PMC8447297
Divekar AA, Patamasucon P, Benjamin JS. (2021). Presumptive neonatal multisystem inflammatory syndrome in children associated with coronavirus disease 2019. Am J Perinatol. 38: 632-636. https://doi.org/10.1055/s-0041-1726318; PMid:33757142
EBM Guidelines. (2021, Sep 13). Klinichni nastanovy na zasadakh dokazovoi medytsyny. Multysystemnyi zapalnyi syndrom u ditei (MIS-C), pov'iazanyi z infektsiieiu COVID-19. URL: https://www.dec.gov.ua/wp-content/uploads/2022/01/multysystemnyj-zapalnyj-syndrom-u-ditej-mis-c-covid-19.pdf.
Gupta S, Malhotra N, Gupta N et al. (2020). The curious case of coronavirus disease 2019 (COVID-19) in children. J. Pediatr. 222: 258-259. https://doi.org/10.1016/j.jpeds.2020.04.062; PMid:32360416 PMCid:PMC7189853
Harapan H, Ryan M, Yohan B et al. (2021, Mar). Covid-19 and dengue: doublepunches for dengue- endemic countries in Asia. Rev Med Virol. 31 (2): e2161. Epub 2020 Sep 18. https://doi.org/10.1002/rmv.2161; PMid:32946149 PMCid:PMC7536968
Henderson LA, Canna SW, Friedman KG et al. (2021, Apr). American College of Rheumatology Clinical Guidance for pediatric patients with multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2 and hyperinflammation in COVID-19. Version 2. Arthritis Rheumatol. 73 (4): e13-e29. Epub 2021 Feb 15. https://doi.org/10.1002/art.41616; PMid:33277976 PMCid:PMC8559788
Lu R, Zhao X, Li J et al. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 395: 565.
Lumley SF et al. (2022). Changes in paediatric respiratory infections at a UK teaching hospital 2016-2021; impact of the SARS-CoV-2 pandemic. J. Infect. 84; 1: 40-47. https://doi.org/10.1016/j.jinf.2021.10.022; PMid:34757137 PMCid:PMC8591975
Mehta NS, Mytton OT, Mullins EWS et al. (2020). SARS-CoV-2 (COVID-19): What Do We Know About Children? A Systematic Review. Clin Infect Dis. 71 (9): 2469-2479. https://doi.org/10.1093/cid/ciaa556; PMid:32392337 PMCid:PMC7239259
Nykytyuk S, Klymnyuk S, Levenets S. (2019). Laboratory diagnostics of lyme borreliosis in children with ticks bites in Ternopil region. Georgian medical news. 11: 32-36.
Nykytyuk SO, Klymnyuk SI, Levenets SS, Vorontsova TО. (2022). C-reactive protein as a biochemical criterion of a general inflammatory syndrome in lyme disease in children. Aktualni pytannia pediatrii, akusherstva ta hinekolohii. 1: 52-56. https://doi.org/10.11603/24116-4944.2022.1.13251
Nykytyuk SO, Klymnyuk SI, Levenets SS. (2021). Lyme arthritis in children. Features of diagnostics. Modern Scientific Researches. 15: 10-12.
Page MJ et al. (2021). PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 372: n160. https://doi.org/10.1136/bmj.n160; PMid:33781993 PMCid:PMC8005925
Patel JM. (2022). Multisystem Inflammatory Syndrome in Children (MIS C). Current Allergy and Asthma Reports. 22: 53-60. https://doi.org/10.1007/s11882-022-01031-4; PMid:35314921 PMCid:PMC8938222
Pawar R, Gavade V, Patil N et al. (2021). Neonatal multisystem inflammatory syndrome (MIS-N) associated with prenatal maternal SARS-CoV-2: a case series. Children. 8: 572. https://doi.org/10.3390/children8070572; PMid:34356552 PMCid:PMC8305422
Sananez I et al. (2021). A poor and delayed anti-SARS-CoV2 IgG response is associated to severe COVID-19 in children. E Bio Medicine. 72: 103615. https://doi.org/10.1016/j.ebiom.2021.103615; PMid:34649078 PMCid:PMC8502533
Stephenson T, Shafran R, Ladhani SN. (2022). Long COVID in children and adolescents. Curr. Opin. Infect. Dis. 5; 5: 461-467. https://doi.org/10.1097/QCO.0000000000000854; PMid:36098262 PMCid:PMC9553244
Takia L, Suresh KA, Nallasamy K, Bansal A, Muralidharan J. (2021). Management Protocol for Multisystem Inflammatory Syndrome in Children (MIS-C). Journal of Tropical Pediatrics. 67 (3): fmab071. https://doi.org/10.1093/tropej/fmab071; PMid:34414434
Vari SG, Shevchuk O, Boychuk A et al. (2023). Common mechanisms of placental dysfunction in preeclampsia, gestational diabetes, and COVID-19 in pregnant women. Ukrainian Biochemical Journal. 95 (3): 5-11.
Vogel TP, Top KA, Karatzios C, Hilmers DC, Tapia LI, Moceri P et al. (2021). Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 39: 3037-3049. https://doi.org/10.1016/j.vaccine.2021.01.054; PMid:33640145 PMCid:PMC7904456
Whitworth HB, Sartain SE, Kumar R, Armstrong K, Ballester L, Betensky M et al. (2021). Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C. Blood. 138 (2): 190-198. https://doi.org/10.1182/blood.2020010218; PMid:33895804 PMCid:PMC8079262
World Health Organization. (2020). Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. URL: http://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020 (Accessed on February 12, 2020).
Zhang Q, Bastard P, Boyarchuk O. (2022). COVID Human Genetic Effort. Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature. 3: 587-598.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Ukrainian Journal of Perinatology and Pediatrics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “Ukrainian Journal of Perinatology and Pediatrics” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license(СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
